“Minting Millions from the Magic Molecule” (Nick Hodge)

WP Greet Box icon
Welcome! If you are new to Stock Gumshoe, grab a free membership here and join us to get our free newsletter alerts with new teaser answers and debunkings. Thanks!
Not new? Please log in at top right of this page

“How to get this $35,000/gram miracle cure for just $0.65″ — that’s the subject line of the latest teaser ad we’re reviewing … how can you resist?

The folks at Angel Publishing appear to be spinning off some of their newsletters, with Nick Hodge headlining, into a new little entity called the Outsider Club — which, as far as I can tell, is just another of the dozens of interrelated newsletter brands that have been built by Agora-affiliated publishers over the years. Some of them catch on and build big mailing lists, some of them quietly disappear.

But this pitch is not really just from this “Outsider Club”, it’s from Nick Hodge’s pricey newsletter called Early Advantage, which has been around for many years at Angel Publishing — it used to be called Alternative Energy Speculator until they realized that particular subsector was losing investor interest a couple years back, and it has called some interesting stocks to our attention, including Westport Innovations about five years ago before they were listed in NY.

So I tend to pay attention to their new picks even though some of the tiny ones end up being crash-and-burn disasters — my readers keep asking about them, and they pick so many tiny stocks that their attentions have a tendency to drive big spikes in the share price. I expect we’ll see the same thing once again here, since this latest teaser pick (which I mentioned a couple weeks ago, but haven’t gotten to looking at closely until now) is even smaller than most.

Of course, such spikes up in price are usually followed by a collapse if the story doesn’t play out as cleanly or as quickly as the ads always seem to imply, but they can at least be fun to watch.

So what’s Hodge’s latest darling stock?

Here’s the teaser pitch:

“… for 5+ years, a team of America’s foremost scientists has been hard at work in a laboratory… working on a Nobel Prize-worthy discovery.

“And it ALL revolves around the giant keyhole limpet… or more simply, the sea snail.

“It’s something you’d ordinarily see in a sci-fi film. But this is very real.

“And if you understand why this sea snail is so crucial — and what these scientists discovered while burning the midnight oil — you’ll be on the fast track to 300x your money profits….

“What was unearthed in a Ventura County lab is something that will alter the way the medical world operates forever…

“Few discoveries in history have had the kind of impact this one will have. It’s simply so game-changing, examples of past scientific developments may be completely pointless.

“We’re treading on truly unheard-of profit territory here.”

Irregulars Quick Take
Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? log in at top right)
Well, we can at least rest assured that the fertile fields of hyperbole are growing nicely in Baltimore, MD — how can you not want to know about “unheard-of profit?”

Even if we know that the reality never matches the hype, there’s still that little part of our brain that says, “what if he’s even just halfway right?”

He compares this advancement to the big antiviral discoveries made by Gilead Sciences (GILD) back in 1992, and shows the dramatic stock move from 50 cents or so up to the low $20s — he doesn’t mention that it took 15+ years of patience and fortitude to enjoy those gains, or how many other companies seemed to have similarly exciting discoveries in 1992 and are now bankrupt, but you get the idea — biotech is one of those areas of the market where huge gains are possible. And even though the fact isn’t hammered into your head everyday the way those potential gains are, you probably area also quite aware that with 1,000%+ return potential you almost always get a heightened risk of 100% losses.

So what is this “Magic Molecule” that’s supposed to make us rich?

Here’s some more from the teaser ad:

“The world-shaking discovery… REVEALED

“For decades now, medical companies around the globe have heavily relied on a compound known as Keyhole Limpet Hemocyanin (referred to as KLH — or what I call the “magic molecule”).

“That’s a fancy name for what essentially amounts to sea snail blood…

“KLH only comes from one place: the giant keyhole limpet, aka the sea snail I showed you a picture of earlier. And this sea snail lives in one very specific part of the world, off the coast of Central California….

“Here’s the key: There are only 100,000 of these creatures left in the wild. Once the KLH has been extracted from them, they die.

“In other words, the hundreds of drugs that rely on KLH — the drugs that assist patients who suffer from cancer to Alzheimer’s to drug addiction — are in grave danger of extinction… along with this specific species of sea snail.

“None of this may seem very exciting, but get this: Because it’s so scarce, the KLH extracted from these sea snails sells for between $35,000 and $900,000 per gram.”

OK, so that’s our little “Magic Molecule” — Keyhole Limpet Hemocyanin. I confess that I had never heard of it before taking a quick look at this story about two weeks ago.

And yes, the Keyhole Limpet was featured in Popular Science as an enabler of a cure for cancer about 18 months ago — an article that is worth a quick read, and that mentions the company that’s farming these mollusks in California to extract their blood.

So is that the same company being teased by Nick Hodge? Let’s quickly check a few more clues:

“Once single company — whose shares currently trade around a mere $0.60 as you read this — is the ONLY company that knows how to extract KLH without killing the sea snail. And they have a patent on it.

“So, not only does no one else know how to do this…

“But this tiny company also has a patent pending for a process in which they raise the sea snails on land.

“That’s what happens when you have the likes of these guys working in your Ventura County laboratory:

  • The board-certified immunologist who, together with his team at UCLA, was the first to discover AIDS in 1980; and
  • the Professor of Molecular Genetics and Biochemistry at UC-Santa Barbara — named one of the 50 leading technology pioneers of 2006 by Scientific American.”

So … yep, this is Stellar Biotechnologies, which is listed on the Venture exchange in Canada at KLH and also trades over the counter in the US at ticker SBOTF (with low volume in both places, this is a sub-$40 million stock and $100,000 in money flowing in or out could dramatically impact the stock price).

And yes, Stellar is the leading (and practically the only, they say) company that’s sustainably cultivating Keyhole Limpets on land, in a controlled environment aquaculture farm/lab, and extracting their blood for use in vaccines. Their current capacity is about one kilogram of blood per year, which doesn’t sound like a lot — but apparently the amount required for each dosage of a vaccine must be infinitesimally small.

KLH is really a vaccine conduit, not a curative compound in its own right (there are other mollusks that have been touted as miracule cures, like the anti-bacterial and cancer-fighting properties of some sea snails that have been in the press in recent years) — it’s a large molecule that’s safe for humans but has a strong immune response, here’s how they describe it:

“KLH is an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. Potent, yet proven safe in humans, KLH operates as both a vital component for conjugate vaccines (targeting cancer, autoimmune, and infectious diseases) as well as an antigen for measuring immune status. Stellar Biotechnologies was founded to address the growing demand for renewable, commercial-scale supplies of high-quality, GMP-grade KLH. Stellar has developed leading practices, facilities and proprietary capabilities to address this need.”

So apparently this KLH stuff is a great base for vaccines — it’s part of a tested compound for dozens of clinical trials right now, including at least a few active trials where they have supply agreements with pharmaceutical companies. You can see several presentations here about their business and technology. The Wikipedia page explaining this protein gives a pretty good broad overview here.

And the stock has climbed nicely this year, following their listing on the OTCQB and rising awareness among US speculators and plenty of news releases from the company about their aquaculture achievements and the progress of potential vaccines for cancer and other diseases, along with, of course, this recent attention from Nick Hodge. This isn’t the first time the company has been a stock market darling, that Popular Science article came a year after the surge of excitement that drove the shaers from 20-30 cents to well over a dollar for a few weeks in late 2010-early 2011, but we’re broaching new highs for the year again here in the 70 cent range.

That means Stellar Biotechnologies now has a market cap approaching $40 million — laughable for the kind of potential market they’re talking about, with hoped for royalties and other revenue bringing in hundreds of millions of dollars a year perhaps as soon as 3-5 years from now (that’s from one of their investor presentations), but very large for a company that has negligible revenue and posts losses in most quarters of roughly a million dollars. They’ll also have to raise money by selling stock, I expect, if they haven’t made any big deals with pharmaceutical companies by late this year.

But that’s probably the immediate upside potential, beyond the possibility that they might get exciting news from one of the current KLH vaccine trials that leads to a rapid increase in demand for the molecule — they say they are “actively exploring multiple, current avenues of co-involvement with 7 of the 15 largest biopharma companies.”

And for a $40 million company, a joint venture deal with a larger pharma company can easily provide enough cash to keep them going for quite a while — and spur some increased investor love.

I have no real sense for what the market for this KLH will be in the end — certainly demand could be very high if there are effective vaccines for Lupus, Breast Cancer or Rheumatoid Arthritis that use this molecule, but it’s not clear to me what the physical capacity is or what the pricing would be in that world if higher demand… or whether the mass market demand for this compound would lead to new ways of synthesizing it and therefore sidestepping the limited capacity of Stellar’s mollusk farm. They have managed to get these creatures to reproduce in captivity, so they’re managing multiple generations of them and can increase capacity over time, but I can’t imagine that they can increase capacity all that quickly.

The only folks I saw actively selling and quoting prices for KLH for labs were selling it for about $10/mg, I have absolutely no idea whether their variety is as good as Stellar’s (or maybe it is Stellar’s, I dunno), but at that rate a kilogram, Stellar’s annual capacity, would be worth $10 million. If Hodge is right and this stuff is good enough that it sells for $35,000-900,000/gram, then that means their annual kilogram of KLH production could pull in somewhere between $35 million and $900 million a year in revenue.

So that’s a pretty wide range, potential revenue somewhere between $10 million and $900 million … which doesn’t count any royalties they might get for their proprietary products or from joint ventures if they really proceed with developing their own compounds for clinical study, as they indicate they might.

So far, though, revenue is more like $250,000 over the last four quarters … which means the low end of that estimate would be hugely dramatic growth for Stellar. Of course, whether or not they can ever reach that low-end guess is an open question — it looks really interesting, I can see that they’ve invested a lot (including government grants) to build this sustainable aquaculture and processing capacity, but with science still proceeding and the vaccine trials still pretty early, I can’t even halfway guess what the company should be worth or whether their product will stand out as a crucial component and see increased demand even if prices rise.

But that’s the long-term imagining about Stellar’s future — most likely, the stock will bounce around like a cork as news flows regarding any of their clinical trials or joint venture deals with pharmaceutical companies, so I wouldn’t expect to see the shares trade on some fundamental valuation based on revenue or earnings anytime soon. File this under “speculation” and be prepared for a bumpy ride if you decide to get on board, I expect that Nick Hodge’s attention (and the attention of our merry band here at Gumshoe Nation) will make the stock bouncy even without any fundamental news (average trading volume combined in Canada and the US is not often much more than $100,000, which is very, very light — don’t count on getting out of a position at a reasonable price if you want to sell in a hurry).

If you’d like to hazard a guess as to what the stock is worth, or whether it’s worth a nibble, feel free to use the friendly little comment box below.

Print this

Email This Email This

111 Responses to “Minting Millions from the Magic Molecule” (Nick Hodge)


    • I have studied this for a long time, you’re absouletly right.
      If you visit someone in the last stages of cancer – they smell different. Their body is usually very acidic. The soil in which our food is grown is depleted and being laced with acid riverting compounds hence the end result.

      Like(0)

      • OTOM: you give yourself away by your opening statement that; “I have studied this for a long time” something relatively few people have done compared to the masses that have been bamboozled by medical propaganda from the “cut, burn and poison” gang. I used to sell hospitals a natural deodorizer from England called Ozlab, which they claimed was the only one they had found that would get rid of the terrible smell from cancer patients.
        As a life long organic gardener pioneered by Rodale et al, I would not only endorse your statement by saying human health is directly related to healthy soil with high organic matter, earthworms and various microorganisms. Chemical fertilizers kill these essential ingredients and eventually produce a sterile soil that is incapable of producing anything without massive injections of chemicals every year. Besides that it makes soils incapable of water retention so irrigation becomes necessary, flooding is more prevalent and bigger heavier tractors are needed to work the increasingly cement like soil.

        Like(0)

    • Hi I am new hear and this is the my first time, be gentle. If you bought this and .65 I hope you sold last Wednesday went it hit $2.30.

      Like(0)

    • Just got Nick’s pitch to buy his $499 book and get the inside tips on SBOTF, looks like it jumped up last week but it is coming down, sits at $1.75 now, heaven help those that are hanging on waiting for it to go back up….

      Like(0)

  1. Breast cancer is acid pH.
    I cured my tumors with alkaline.

    This product muzt be alkaline.

    I would not think this is a buy & hold.

    Cancer cannot live in 8.5 pH.

    Stop worrying about losing your life’s savings if you get cancer.

    There has always been a cure.

    Like(1)

    • Right, cancer and virtually all “dis” ease is PH related which is directly related to O2 levels and O2 uptake by the cells. Otto Warburg won a Nobel Prize in the 1940′s for this revelation. The Cancer Industry knows this and stomps down any doctor who tries to use O2 or PH related means to “cure” cancer. Dr. Simoncelli of Italy injects baking soda directly into cancer tumors and DISSOLVES them. Don’t believe it? Go watch it on Youtube. Gee, why doesn’t our magnomous “Health” Care industry tell us about this or use it? Because baking soda is $2 a box. Duh.

      Like(1)

      • I’m proud to say I’m a direct descendent of Otto Warburg. I also have used Baking soda to brush my teeth for most of my lifetime and have no gum problems (though I figured that one out on my own). My dentist always remarks on how healthy my mouth looks though he gives sme a tube of toothpaste after cleannings,.It’s Highly recommended that you throw out the silly expensive Colgate, and buy yourself a box of Arm & Hammer. It’ll last you well over a year and your teeth will thank you (and don’t believe the hyginist when she says Baking soda will wear the enamel on your teeth. It hasn’t done any such thing to mine.)…oh, my heavens!! I just read DAvid Clumpner who says the same thing.

        Like(0)

  2. wow, bonnie , you just rattled atrillion dollar industry there..care to throw more light on that, can contact me at ‘madhupgi’ gmail

    Like(0)

    • Bonnie and Bob are spot on Maddy.
      There’s a LOT of excellent research on google and youtube about the acid
      alkaline connection to all disease.
      Many state of art dentists are now telling their patients to throw away
      their toothpaste and brush their ENTIRE mouth with baking soda and sea salt the VERY
      last thing b4 retiring so your mouth’s environ is totally alkaline all nite long.
      Baking soda and magnesium (epsom salt, milk of mag, or citrate) are excellent for
      the outer as well as inner environment but the most important thing of all is to eat a LOT of veggies and get a juicer as well.
      My yahoo email is archives2001

      Like(0)

    • Theres the rub Maddy, it has been said that “more people are making a living from cancer than are dying from cancer” so FOLLOW the MONEY! It is hard for any decent thinking human to believe that anybody would put MONEY ahead of TRUTH and the best interests of their fellow man. It is a harsh reality, but even idealistic people get sucked in and then find it hard to take a stand and find a more moral means of earning a living once they become disillusioned with the direction of the profession into ever more expensive and destructive “cures” ?? when their eyes are opened to the reality of the forces allied against them.

      All the more reason WHY we should dedicate our charitable donations to organizations that are focussed on EDUCATION and natural means of health promotion instead of the foundations of disease perpetuation (as I see them) with their “runs” or ribbon campaigns for this or that, when all they are doing is milking the public to increase the profits of drug companies.

      Like(0)

  3. I went to the Sigma Aldrich website ( I used a lot of Sigma products when I worked in clinical labs) and they sell this in 20 mg vials for $70.40, a five pack is $264.00. That’s about $3,500 for a gram. I wonder If Nick Hodge made a metric conversion mistake? or are these snails really that hard to farm? My garden snails love Sam Adams beer, maybe these little guys need some incentive to multiply. If you use a Ichimoku Cloud indicator that predicts 26 bars out, SBOTF will bounce back down to 0.56 cents by June 24. I’ll keep it on watch for awhile.

    Like(0)

    • I have no idea what the prognosis is or how hard it is to farm them — part of the impetus for them getting grant funding was to protect the wild population of these mollusks, who apparently are being harvested too fast for this very reason. I don’t think anyone else is trying to farm these little guys yet, or what leeway there is for other folks to do it without impinging on whatever patents they might have, but I expect that if prices rise to those crazy levels the market will respond.

      Like(0)

      • Different grades are different prices, but I also saw on another website that stellar sells it to sigma… thats the lowest prices ive found on the interest for it, and the highest price is 70,000 a gram. found 4 or 5 websites to get it from so far

        Like(0)

  4. A scientist with one of the algae companies recently used an algae to formulate a
    way to use an algae substance as an injection carrier to inject a cancer cure
    medicine. He claimed to be successful but stopped when several others were basically doing the same thing.

    Like(0)

  5. attention Bonnie Ember in which journal did you acquire the information that this snail has a pH of at least 8.5 and in which journal did you acquire the information that it takes an acidic pH for cancer to survive and thrive a normal pH in a perfectly balanced functioning human being is 7.35-7.45 with a bicarbonate used to buffer and keep check out of wack pH disorders whether they are respiratory or metabolic of at around 30-40 . no animal that i am aware of can sustain a abnormal low or high ph without longterm respiratory and metabolic internal adjustments taken over many years and how are there millions of people walking the street right now with medically controlled electrolytes with normal pH CAN you explain this and how did you get rid of your cancer while surviving a deadly alkalotic pH of 8.5 i certainly and i think the whole cancer community would like to know what ground breaking new way to be treated and cured is and how you survived an 8.5 pH HOW AND FOR HOW LONG AND BY WHAT MEANS AND WHAT HAPPENED TO THE REMAINING TISSUE AND CELLS THAT YOU HAVE CURED …………………………………………..

    Like(1)

    • Thank you, John O’Connor. I was wondering the same as you and would love to read the data supporting the given statements made by Bonnie.
      As to the possibility of this item being worth the investment…there are a lot of “maybe’s” involved here, so I would probably do some more research, but am not feeling like it would be a good buy at this time.

      Like(0)

    • The disease/cancer – acid environment connection was a Nobel prize discovery by Dr. Otto Warburg maybe 75 years ago.

      Like(0)

  6. Pinnacle Digest has profiled Stellar as a featured company in the past! They still may be a featured company. I have personally met with the CEO at a conference in Nashville, TN at Vanderbilt University and am a shareholder.

    Like(0)

  7. Hey John O’Connor no need to shout ask the question and wait for an answer, play nice this is a very friendly community.

    Like(0)

  8. Just like martial arts, 200 shares for $160 in my IRA isn’t bad at all.
    After all I was dumb enough to pay $1900 to buy Vantage Point prediction software, so this is cheap and fun and I love the comments.

    Like(0)

    • Captschnuff, I have no idea what your knowledge level is but yr suggestion that Dr Mercola is a Quack is definitely suspect as being motivated by the Pharmecuetical Industry, I have been for almost 40 years a Naturopathic self healer and if nothing else Dr Mercola alerts people about the harmful effects of modern medicine and I applaud him for that. It is true that he has products for sale but so what ?

      Like(0)

  9. A limpet is not a snail of any sort. Yes, they are both mollusks. Did everyone sleep through general biology? Knowing taxonomic relationships among organisms (systematics) is key to chasing down potentially useful molecules in them. Anyway, nature originates the active agents in most medicines but efficient commercial exploitation usually depends on synthesizing the molecules once they are discovered.

    Like(0)

  10. The powers that be will always try to destroy any cure for diseases like cancer, diabetes etc;
    as there is too much money in the treatment. Its why they tried to destroy Dr Burzynski and his cure for cancer that has been shown to be very effective. Big Pharma wants everyone on 4-6 drugs to keep the profits coming. Almost as evil as Monsanto.

    Like(0)

    • ALMOST? In terms of negative influence on society in general’s perception of reality and truth, try double, not that I would in any way endorse Monsanto. You are however right on the money when you imply the “powers that be” try to destroy anyone that would under-mine their profit machine managing disease instead of preventing them and putting them out of business. This is a cartel, in bed with, and endorsed by government.

      Like(0)

  11. Puleeze! Activate your common sense switch. Why in the world would big pharma pass up proven cures for the above conditions since, if such cures were found, they would mean even bigger profits for pharma? They simply haven’t been able yet to develop effective new cures yet, try as they might — even if not out of the goodness of their hearts then for their bottom lines. Such discoveries would be BIG. Also pls be advised that Burzynski is yet another certified scammer-quack. See http://burzynskiscam.com/ and http://www.quackwatch.org01QuackeryRelatedTopics/Cancer/burzynski1.html

    Like(0)

    • Big pharma cannot charge for what is found in nature. They make money on chemical structures devised in laboratory settings that more often than not, provide small benefit to the consumer – if any at all. Speaking of common sense: shouldn’t we apply it when considering the likelyhood of the creator providing natural cures to not simply perpetually “treat illness”, but actually ‘cure it?

      Like(0)

  12. While everyone is entitled to “their opinion,” after reading the “quackwatch” post by “captschnuff” I am offended by the allegation that BOTH Dr. Mercola and Dr. Oz. are “card carrying quacks” based on what, their disagreeing with medical orthodoxy? it is clear to me that this is a highly biased medical propaganda vehicle intent on denigrating any competition. While I do not doubt that some quackery exists in the alternative medicine field, judged by the same standards as the medical establishment uses to define “quackery” among their competition, there is far MORE quackery in the medical field itself. They need to clean up their own act before pointing fingers at dissenters.

    The simple truth is that there is no such thing as a 100% “safe drug” even aspirin kills hundreds of people every year, ALL drugs have side effects and are properly designated as “poisons” that are potentially harmful, sometimes taking years to manifest themselves.
    With the fastest growing class of diseases being “IATROGENIC” (doctor caused) the medical profession has enough skeletons in their closet that they are ill qualified to pass judgement on other approaches to healing and health. At their best drugs merely alleviate symptoms and do NOT promote health, in fact they MASK problems that could be alleviated by a positive change from the destructive lifestyles practiced by the average consumer.
    Dr. Mercola and Dr. Oz have attracted a following because they as medical profession “insiders” have seen the destructive results of medical practice and been willing to take a stand against unnecessary surgeries and the indiscriminate use of harmful drugs.
    PER asks; WHY in the world would big pharma pass up proven cures” and the simple answer is, because they can’t patent and control natural remedies and therapies.

    Like(1)

  13. Any one is of course free to follow any path he/she chooses — evidence-based or anecdote-based. Medicine is still an largely an “art.” Some things work in some people, some things don’t work in other people. Nothing is or ever will be “100% ‘safe’” and that includes the very phenomenon of being alive. No question that a healthy lifestyle is extremely important yet, when bad stuff happens, I prefer peer-reviewed science-based medicine. Others may prefer to consult the hit-or-miss-type naturopathic doctors of the Amazon or New Guinea rain forest persuasion, because SOMETIMES their treatments make the patients better. And of course, SOMETIMES their patients die.
    Here are a few articles among many that obviously won’t change any made-up minds. They deserve some level-headed perusal by all persuasions.
    http://www.sciencebasedmedicine.org/index.php/for-shame-dr-oz/
    http://www.chicagomag.com/Chicago-Magazine/February-2012/Dr-Joseph-Mercola-Visionary-or-Quack/index.php?cparticle=3&siarticle=2#artanc
    http://www.newyorker.com/reporting/2013/02/04/130204fa_fact_specter
    (Summary of the lengthy New Yorker article above is here):
    http://scienceblogs.com/insolence/2013/01/29/the-great-and-powerful-dr-oz-dissected-in-the-new-yorker/

    Etc. etc…

    Like(0)

    • Holy Moley, what was that mike sanders said about this being a (friendly community) ???
      gee tony, its just a stock tease. no need to go all political on the (community) have a nice day :) .

      Like(0)

    • Every two days in America there are approximately enough people who die due to iatrogenic diseases (doctor-induced disease) from PROPERLY PRESCRIBED pharmaceuticals to fill three jumbo jets. If there were that many people dying in jumbo jet crashes that often there would be a national uproar and hell to pay in Washington to do something about air traffic safety. But there isn’t merely because it’s happening in quiet wards in hospitals or in homes, spread all over the country, not spectacular conflagrations in front of crowds. And these are the ones that DIED, while far more survived to continue suffering the damage wrought by properly prescribed drugs. This doesn’t even include the damage done by MISTAKES made by allopathic practice. The public is told to believe that such damage is ‘the price of medicine.’ To me, it’s just gambling with your life and health.
      I personally know some people who collected published papers in medical journals on the hazards of various aspects of modern medicine. It made a stack totaling over 40 feet high, and was still growing after about 6 months research when they stopped because it seemed endless, and clearly made the point. It also brought home an observation: a narrow knowledge is a dangerous thing. Allopathic treatments are almost completely symptom driven; it very often treats the symptom but harms the patient in other ways rather than correcting the underlying cause and promoting overall health of the patient. Even some of the diagnostic methods are harmful.
      Allopathy knows virtually NOTHING about what it means to be healthy, and does pitifully little to find out. Most medical schools don’t even teach anything significant about nutrition—a few days. Doctors are so much influenced by pharmaceutical companies that they have effectively become drug pushers, not health promoters. Patients looking for the cause and cure of chronic disease are often just given prescriptions to ‘control’ the disease. A friend of mine had dizzy spells, the doctor zapped his thyroid, then prescribed thyroid drugs for the rest of his life. There are very effective alternative treatments to bring the thyroid back to healthy functioning.
      Americans pay the most for ‘disease care’ in the world yet rank around 40th in the world in real health.
      Don’t complain about doctors trying to inform the public about alternatives to such hazardous practices. There are some useless and even some harmful alternatives but there are also some incredibly beneficial alternatives that even defy the conventional ‘wisdom’ of modern medicine. Even chronic diseases CAN be cured. You just have to look for those with the best knowledge and time-tested treatments. Judge by the results, not the methods. That’s real science.

      Like(2)

      • WOW STEVE, great response, glad to know there are others out there who are in tune with reality. There is no reason that falsely called “medical science” (since it is NOT a science) should be held up as some kind of “standard” against which all other modalities are measured. On balance the medical profession probably does more harm than good. You are right, they like all others should be judged by RESULTS and compete in a free market on that basis. Nobody should be FORCED to accept their poisonous nostrums including inoculations yet more and more laws are being enacted to get universal coverage. Yes the medical professionals are indispensable in saving lives in cases of accident and some drugs may be justified temporarily in emergencies, but in terms of health you are correct in labelling their services “disease care” or as I have for decades described it, as “disease management” or “symptom suppression” not health production. Health results from a sensible and balanced lifestyle that includes pure air and water, regular exercise and most important balanced nutrition from natural foods, primarily foods and vegetables, FRESH meat in very limited quantities and likewise dairy, particularly if you do not have access to unpasteurized raw milk for cheese and yogurt. Milk promoted for its calcium is designed to produce a 1000 lb. plus animal, if you must drink milk then goats milk is a much better choice and much easier to digest, but there are other choices, almond milk being one very healthy choice to promote P.H. balance so essential to avoiding dis-ease. The whole “germ theory” of disease is badly flawed. We all have various bacteria, germs etc. in and on our bodies both good and bad and they are naturally kept in check when we eat a healthy diet. I view that whole “virus” hysteria as nonsense, when your body is properly nourished and your IMMUNE system is up to snuff then the body is able to prevent the proliferation of any of the viruses, germs etc. that are identified, they are in effect “nature’s garbage disposal crew” so AVOID the garbage in the first place and your body will prevent the out of control proliferation of the viruses, germs and bacteria that are a natural part of our environment.

        Like(1)

    • DAH! This statement, “SOMETIMES their treatments make the patients better. And of course, SOMETIMES their patients die.” strikes me as ODD coming from a defender of the medical profession, surely it applies in spades to them equally. While I am not aware of any such statistics being available, I would BET that based on number of patients treated and patient deaths, the medical profession would have a far higher percentage than any other method of treatment, and growing worse. Even those statistics (if available) would be skewered by the fact that most people will not seek help outside the medical profession BEFORE their treat-ments have failed them, and in many cases further damaged their fragile immune systems.

      Like(0)

    • >>Here are a few articles among many that obviously won’t change any made-up minds.<<
      Exactly, Per, so why waste your time? It's not worth the trouble.

      Like(0)

  14. I am SO tired of these Wunderkind stocks. One of the commenter s hit it on the head….”short term profits”……The stock is hyped by Nick and other con artists…we suckers buy it and once they make 1000% profit they sell. Thats how the short term profit is made and once the stock collapses,… you have certificates you can use on the bottom of your birds cage.
    The market is fixed. The pigs who brought down the economy in 2008 all got gov’t jobs……we spent billions because GM and others were “too big to fail”….baloney…in 1900 Roosevelt ( Teddy) broke up the cartels and business people bought up the little companies and made fortunes. Same would happen if a giant collapsed….people would buy up machines and receivables on pennies on the dollar and life goes on.
    There is NOT a level playing field. Warren Buffet goes and sees Bozo Obama, and the next day the talks about the oil pipeline bringing crude oil from ND is killed. The oil will now be carried by Burlington Northern RR, owned by………Warren Buffet.
    My security is what I can bury in the ground and hide from Home Land Security when they start rounding up Americans and taking them to the concentration …ur sorry…detention camps,… that HS built.
    Former Free American….now waiting for the hammer to fall……
    USA….R.I.P……1776-2008

    Like(0)

  15. I thought Otto Warburg said that cancer likes an environment low in oxygen.
    He may have said it likes acid conditions too. I don’t know.

    Like(0)

  16. I agree with Deborah in that Hodge went just a little too far in his tease re Stellar Biothech. Like her, I took what was said in the seemingly endless presentation, entered a few keywors in my search engine, and withing 10 minutes had identified the company. I was intrigued. At the time it was trading at .73 and not really moving. I had some cash ready to go in a personal, taxable, account, but wanted to own Stellar in my IRA. A pension rollover was due to be transferred into that account in September or so, so I waited. And watched. Then, with no news to support it, the stock bounded to the .93 range. Waiting didn’t seem an option. So, I made a decision that was far outside my normal investment rules. I decided that, whith what I had learned of the company, it’s product (KLH), it’s market dominance, it’s extensive portfolio of patents, it’s R&D efforts, it’s alliances and agreements with some of the worlds largest Pharma to supply them with top quality KLH for their work, and the fact that Stellar wasn’t just somebodies hopes and dreams, but instead a 25 year-old company with REAL sales, REAL growth, and a REAL dominance in a market niche that was both exciting and NECESSARY in the world of pharmaceutical bioenginering, I made Stellar my”Brass Ring” holding. By that I mean I made it my one and only holding to which I attached the possibility of being “the one” that might pay off in the future in extrodinary ways. I set a 5 year time limit, a price minimum of $5.00, and I bought 10,000 shares at .93. Since then – and it’s only been about 6 weeks ago – I’ve seen it spike up to the $1.12 – $1.15 range, then fall off to the $1.00 or so level three times. It has become a very tempting trading opportunity to me, but I resist the urge. I’m holding for what might be the big winner. The last time I took a plunge like this and bought another “Brass Ring” was in 1986 when I discovered a very distressed company that provided an absolutely necessary service and was failing miserably in doing so. But it had no competition at all (by government decree) and was begging for somebody to come in and buy it out. That company was TFONY – Telephonos de Mexico – at $0.12 a share. I was working as a Financial Advisor with Merrill Lynch at the time and I placed the stock in as many client speculative portfolios as I couls. That wasn’t many – few believers in a down and out Mexican company being run by a totally corrupt and inept government. When my time constraints on a personal investment passed, I bought it for myself. Within 8 months or so, a major telecom came in, made the Mexicans an offer they couldn’t refuse, and the price shot up to the $0.85 area near overnight on the rumor. I grabbed that Brass Ring and cashed out. Probably the best trade of my life. And now here is a very different company with a very different product and with very different management and outlook. But like TFONY, it has no coverage to speak of (yet) and can’t be held in mutual funds, ETF’s or other suj vehicles that can provide both coverage and price support. But that day will come. Stellar will move off the pinks and onto NASDAQ and the party may began. I’ll be there for it, for better or worse. I don’t think there is much chance I’ll lose money in the end. How much may be made is anybodies guess. Check back with me in late 2018 and we’ll talk again.
    Disclaimer: I am long SBOTF and may add to my position at anytime
    “Si Vi Pacem, Parabellum”

    Like(0)

  17. Now that is what I call “intelligent speculation” not where you should put your rent money and probably no more than 2% of your portfolio, but stocks like these with a small commitment CAN pay outsized gains. I have a candidate upcoming for my column on the 16th.

    Like(0)

    • Look forward to seeing what your “Brass Ring” candidate will be, Myron. I’ve been a risk taker all my life and these things just intrigue me. I know on an intellectual level that they are much like a financial lotto and the odds are heavy against the investor in seeing the kind of payoff you hope for. But still, just like the justification that lotto players use (I’m not one of those), the saying is that “no matter the odds, somebody wins everyday.”
      Note to Travis: I’m flattered that you chose to feature my comments. When I first saw the blurb and noticed that it was from a new Irregular member named Jim I thought it was some coincidence that there were two of us. Couldn’t be me. But it is. See, what did I say above? No matter the odds of something happening, sometimes you win! :0) Heck, if I had any idea at all that this could have happened I’d have taken a lot more care with my spelling and typos!

      Like(0)

      • Hello Jim I am very impressed by your comment and the reason you chose this stock . I am a novice at investing in the stock market but I am educating myself with a few books on the subject and I must say your reason for choosing the company are sound to me. You are not trying to hype it up or act like you are some kind of guru in the stock market and you have clearly stated that you are taking a gable on the company. Honestly I am thinking about investing a few dollars after I do my due diligence and research the company . Thanks for your comment and Thanks Travis for choosing to feature it.

        Like(0)

  18. Sounds like it might be worth a shot (a small one) but it’s kind of like playing black jack with the dealer showing a 5. I usually take the double down; don’t always win but the odds are better. It is the rest of my playing that costs me money. But if I can throw down $200-$300 at the tables, why not put it on sea snails at 20:1 odds? There are a few others I have in my “Gambling Portfolio” one in Energy and two in Bio. The energy play is Genoil GNOLF and the bios are Cortex CORX and Adherex Technologies ADHXF. They all have proprietary technologies and patents as well, what they don’t have is the money they need. But if they are able to get it I might find that card I was needing to fill my inside straight. THESE ARE PLAYS THAT YOU NEED TO BE WILLING TO LOSE WHATEVER YOU INVEST IN THEM! Does anybody else have a comment on them?

    Like(0)

  19. It is a good time for SBOTF as only some smart money is in but not a lot like GTI. It sure is intelligent speculation with smart money betting as it is always on the winning side. In SBOTF case if smart money gets in, small timers will be a little late. Now is the good time as I got in at 0.74 for a $1000 which maybe peanuts for a lot of gumshoers but I will not loose my shirt even if it crashes and burns. BTW, if Myron throws a bone to our corner from his upcoming speculation on the 16th, that would be nice.

    Like(0)

  20. I agree with Myron Martin that Dr. Oz and Mercola should not be considered quacks. It is easy to disparage professionals as quacks without any facts to back it up. Both of these doctors are willing to explore new ground and try new approaches to helping people with their medical problems. Mercola does back up most of his claims with research references. One can disagree with his conclusions and recommendations without branding him or Oz as quacks. What makes some of the medical doctors less credible is when you skip to the end of their presentations and see that they are promoting a product that makes them tons of money. In both traditional medicine as well as non-traditional medicine, there are big differences of opinion and in particular, with regard to cancer cures. I do think there are treatment approaches that are simple but unpatentable that keep big pharma from being willing to put money behind some potentially promising curative efforts, whether it’s baking soda or coconut oil.

    Like(0)

    • Just to back up Don’s observations, what makes Dr. OZ and Dr. Mercola and Jonathan Wright and a whole host of other renegade medical doctors creditable is the fact they took the standard medical training and “practiced” for many years, practiced being the operative word and from the INSIDE saw with their own eyes and first hand experience that it was a “money machine” and highly controlled to disparage and censor dissidents. Dr. Oz is still a highly competent heart surgeon but honest enough to admit there are are better solutions that would PREVENT most of the cases he has to deal with in surgery, and the same holds true for many more disillusioned medical doctors who on a daily basis see the terrible state of health of people eating the Standard American Diet (SAD) that would in time, bankrupt the country under Obamacare, as if it wasn’t already.

      Like(0)

  21. Jim,
    Time will tell, I am always interested in biotech stocks and funds, on average my picks are at 48-60 % for the year. I feel strongly enough about Stellar to visit the operation on my trip to CA in September.

    Like(0)

    • Deborah:
      I’d love to be able to visit the facuility too. But I line about as far away from there as possible – South Florida. Please, after you make your visit, write up your observations and share with the rest of us.

      I’d add to that re the location this thought: when I first viewed the tease by Hodge I noticed he was interviewing a couple employees out in the open near the production / breeding pens. Behind them, in the not-so-far distance, you could see a large body of water extending out to the horizion. So, maybe they are located on a bay or perhaps the ocean itself – I don’t know but sure would like to. If it’s the ocean, I’m guessing that is to provide them with seawater from as close to the little natural breeding grounds as possible. We’re not told why, exactly, these Keyhole Limpets are found there and only there. Maybe ocean temps, seasonal changes, currents, nutrients, type of ocean floor, depths, or some combo of all these things. A question I’d ask. But what I mainly want to know is this; if that is the actual ocean, and they are located within such close proximity to it, is there no danger of a Pacific hurricane, typhoon, or tidal surge that could come in aand in 60 seconds wipe out all thier physical plant? I live under constant threat of hurricanes and storm surges in that I’m only about 10 miles inland from the Atlantic. I’ve endured some horrific storms, suffered a great deal of damage, and appreciate the way these disasters can sweep in and take out everything. Is Stellar at risk of this? Please inquire – and let us know.
      Finally, yes – this is a huge GAMBLE, folks. I’m willing and able to take the risk of seeing $7500 or so evaporate. I’d hate it, but it won’t change my life. However, if that $7500 turns into someting north of, say, $40,000 in the next 5 years, that will make a difference to me. Buy me a new Harley for instance. Since I’m in my mid-60′s, I don’t have 20 years to wait. Gotta make hay while the sun shines, you know? So, if you have the wherewithall and nerves for it, climb aboard, pay the fare, and hang on for dear life. It just may be a wild ride!

      Like(0)

  22. See the problem with biotech is there is always someone just around the corner with a better technology or who will use your technology as a stepping stone. I personally have a Degree in biotechnology and work in the pathology industry. This key hole limpet has this KLH protein which is synthesised within the cells of the animal from 1 or more genes. All another company has to do is remove this gene from the limpet and splice it into a nice little bacterium. The bacterium can then be grown in a huge vat and produce this protein cheaply and effciently (they do the same with insulin production). Now if they own the IP of the gene or genes that produce the KLH that is another story, better to own the gene then to own the method of extracting the KLH from the animal. I see another company (possible the drug companies themselfs) creating a transgenic bacterium capable of producing the KLH because of the outragious cost of extracting it from the animal. When that happens stellar won’t be worth much.

    P.S. One of the courses with my degree was biotech finance, long story short biotech is extremely risky to invest in and our lecturer made sure we were well aware of that, the percentage of failures is huge.

    Like(0)

    • Shaunus:

      Thanks for your reply to my post. Before I comment on it, allow me to say this. I would never get into a debate with you about Bioengineering. You tell me you have a degree of some sort in that field which would put me at a serious disadvantage. Other than the B.S, degree I earned back in the dark ages – the “B.S. standing for “Bachelor of Science”, not the more common street definition of B.S. The only degrees I have gotten in recent years are the several third degrees I got from my ex-wives divorce attorneys. Those would not be of much help in supporting my views on this subject.
      I’ve read your post three times now and here’s my takeaway from what you are saying:
      (1) You believe that any biotech or Pharma company that wanted to could sweep in, synthesize the KLH protein from the genes of the Limpet, whip up a big batch of KLH in a vat, and produce an endless supply of the protein at little cost for their own uses. That about it? Well, I always ask questions and here’s mine: if it’s just that easy, why hasn’t somebody done it already? Why is SBOTF still in business? This is just one thing that makes me go Hummmmmm.

      (2) Your “lecturer” in a class told you that investments in biotech was “extremely risky” and that the “percentage of failures is huge.” Now, don’t think I’m just trying to be snarky here or too cute .. but did it really take a college level course to learn that? Shaunus, if a person does not recognize those simple and basic facts about investing in any form of cutting edge or new technology they really ought not even be allowed near a trading desk. Please don’t take offense – I’m not trying to insult you. I’m just saying that if the fact that investing in a company like Stellar Biotechnology is deemed “risky”, well, caveat emptor. You can say that about ANY tech company from any point in time. GE was once a “high risk” company. People thought that electryfying a house, much less a city or entire Nation would certainly result in catastrophic fires and deaths. Think about Apple Computer early on. Intel. IBM. Microsoft. Etc., etc., etc., ad nauseum. New ideas and new technology are ALWAYS thought of as very hgh risk in the developmental years.

      (3) So, Stellar Biotech is risky and carries with it the possibility – even a high possibility – of never becoming what some like me think it has the possibility of becoming. Very true. But it also has the possibility of becoming a highly profitable company providing a critical element for R&D (KLH) in the Pharma industry (and perhaps holding great benefits for developing certain specific applications for treatments on its own) while holding dozens of patents on it’s processes that prevents other companies from stealing their intellectual and proprietary property and doing it themselves. Phew! – a run-on sentence as my English tgeacher liked to tell me. Sorry.

      Conclusion: If the percieved risk of investing in SBOTF or any other company is too much for you to bear, stay away. It’s that age-old idea of heat and kitchens. If you are like me and the risk is acceptable in return for the hoped returns later on, get in there and start cooking. It’s that simple. But never simply dismiss an investment opportunity out of hand just because it may fail. ANYTHING can fail. That’s the nature of this beast we call “investing.” Good luck out there!

      Like(0)

      • I know this is an old thread, I am reading up on a few things, this however caught my eye. Please I am not being ;snarky or trying to start up anything, just pointing out that sometimes, just sometimes, where there is smoke, there is fire….and not in a good way.

        Jim you said, to shore up your argument “….You can say that about ANY tech company from any point in time. GE was once a “high risk” company. People thought that electryfying a house, much less a city or entire Nation would certainly result in catastrophic fires and deaths. ..”

        Umm yep they did, and were they wrong? In he USA alone, there are appx 400,000 electrical fires each YEAR, resulting in approximately 3,000 deaths, 13,000 debilitating injuries, with total approximated costs near 8,000,000,000 (billion) dollars PER YEAR. EVERY year on average. Acceptable risk-return?

        Like(0)

  23. I don’t believe in “big Pharma” and their sometimes dangerous prescription products. However, I try to not let this personal bias keep me from making some money off those same companies. So, I have decided to go ahead today and place a significant bet (for me) on SBOTF. Yes, Stellar is not big pharma but their customers certainly are. The product is in fact a natural extract derived from sea life and that sort of thing does attract my attention as most of the supplements that I do take are derived from natural plant or animal life. Last year I was attracted to a smaller company that was showing great success in some clinical trials. As trial results progressed it was very obvious that the investors were paying attention as the price was steadily going up, so I bought more of the stock. This continued and in spite of the higher price, I bought even more of the stock. Then a sudden change of situation occurred. A BIG company wanted the small company and I did very very well on the buyout offer. Oddly, the special medical product that caused the buyout has disappeared from this earth. Appears that the buyout was used to prevent the new stuff from competing with the buyers old stuff. Such is the extent of greed sometimes demonstrated by the big pharma companies. Perhaps someday the buying company will see fit to produce the medicine which they scooped up. Perhaps someday SBOTF will be bought out by one of its customers. If that should happen, I will be hoping for a fat jump in price.

    Like(0)

  24. Global Investing’s editor (me) and my paid subscribers are benefiting from a new boost in biotech stocks which so far in 2013 has led to two takeover bids for shares we own, one Israeli, one Canadian. And a third, out of Belgium, which now employs our former Italy-based Biotech Maven, is looking good.
    And last week another Israeli pharma IT company is soaring too thanks to a deal with a drug and chemical major.
    I think that this is an investing trend and the origin may be in the USA. But we are not into key hole limpets unless I find a foreign firm in the area, in which case of course Stellar will be less stellar.

    Like(1)

  25. I would like to learn ticker symbols of the companies you recomend. Now I only own one pharmaceutical co ALNY.

    Like(0)

    • Alex:
      The company under discussion here is Stellar Biotechnology, symbol SBOTF. It trades on the pink sheet which might cause you to have to use the trading desk at your brokers firm to execute orders. This isn’t hard or expensive – just ask your customer service service at the firm through which you trade.

      What is making this discussion a tad confusing is that there is really two subjects that have become intertwined. One subject – the primary one – is the company itself, Stellar Biotechnology and it’s prospects. The other subject that has become involved is that of using organic cures for treatment, prevention, and cures of diseases vs. the traditional medicine and the role big Pharma plays in that. Stellar IS NOT a Pharam company per se. They provide a substance, a protein called KLH, to the Pharma companies which need it to perform R&D on new drugs and conduct clinical trials. The posts from Myron “Doc Gumshoe” focus on the medical worlds conflicts on how to best treat disease and prevent it in the first place. Other posts are comments on the potential future of SBOTF. So read the posts that relate to which of these areas you are interested in. Just don’t confuse comments on SBOTF with those regarding pharmaceutical companies and what they do. SBOTF is INVOLVED with Pharma companies – they are its customers – but is not (yet) technically one of them.

      Like(0)

  26. Jim,
    A good site to look at is (blogs trans world news stellar group sea snail California) in search engine. I do know that Stellar has a license granted by the US Navy Base at Port Hueneme, Calif. and the farm is land based. The gastropod snails (Keyhole limpets) are raised in tanks and are well cared for. To Answer the question about a copy cat form of KLH, It is virtually impossible to synthesize KLH protein, due to the size of the molecule. However If Shaunus Brousek can do it, I will send some of my investment money his way.
    I am not sure about hurricanes or typhoons, Port Hueneme is near LA, I have not heard of any wipeouts on the west coast. I live in Alaska so I think the distance is about the same as from Florida to LA. I will let you know

    Like(0)

    • DeborAH:
      Your comment re Mr. Brouseks’ contention about the ease in which someone could synthesize KLH reflects the view I somewhat tounge in cheek replied with. If it’sthat easy, why hasn’t anyone done it and cashed in? Imagine the embarrasment around the Stellar boardroom when they found out that they had wasted some 20 years and may millions of dollars trying to get this right only to see some upstart with a few Limpets, a big ole vat, and some bacteria make commercial grade KLH! As for me, I’m not very concerned that this will happen.

      And my houghts about exposure to natural disaster given the location of the plants is born more from my 40 years living near the ocean edge here in South Florida and getting pounded by some bakers dozen hurricanes – large and small – over the years. Living through those things and then having to do the rebuilds it requires tends to make a person a little gunshy. I know zip about weather patterns in coastal CA, but do know the general area sits on the verge of earthquakes (as bad or worse as hurricanes) and possible Tidal waves coming from the Pacific Rim. So I wonder – just in case, does Stellar have a back-up plan in place to deal with that possibility or could we just see our investments washed out to sea one fine day? But I’m not gonna lose any sleep over that concern, just curious.

      Now, a heads up: Later tody I’ll be writing a post about the market action in SBOTF today and what I did about it – or tried to do. As of now, 1:45 PM EST, I don’t know the result of my actions. Stay tuned ..

      Like(0)

  27. Jim,
    As of market close today my SBOTF keyhole investment is at 73.66%. and yes sometimes I invest on 50/50 research and gutt. The fact that Stellar is not a kill and get rich farm had me on the 50% gutt.

    Like(0)

  28. It was a bit of a wild ride for Stellar Biotechnology today. Opening at $1.06, it almost immediately shot up to $1.14 bid, $1.16 ask. By noon it was trading within those bands and stayed put, closing at $1.14 ask. Most impressive was volume coming in at 461,473 shares – roughly 3X the normal flow.
    I’m just guessing, but I suspect the strength of both price and volume can be traced to the fact that Nick Hodge released his teaser on the company – again. Same video as before. That’s knowable because he still quotes the price at ‘around 0.60 per share” in the presentation. You’d think he’d modify that so the presentation wouldn’t be so dated, but he hasn’t. No matter. By now most people that want to know what the company is have found out and can see for themselves.
    As for me, I’m a happy camper regardless of why the price is moving. For those who may have missed my previous posts, I bought on July 18 at 0.93 per share. Had been watching for a few weeks previous as it hovered in the 0.73 area, then it popped (like today) to the 0.93 range. Enough was enough and seeing it get away from me, I took the plunge, buying what is a sizeable number of shares for my little portfolio. Enough so that if it works out as thought it might, it can make a real difference to me. But not so much that if it folds I’d have to change my lifestyle. It’s my “Brass Ring” as I like to call these things. Right now I’m up 25.01% in just under a month. Not too shabby so far.
    Above you’ll see a reply I made to Deborah in which I said I’d relate something I was attempting to do today but wouldn’t know the result until market close. Well, the market has closed and here’s what I was doing. I relate this just because I think a person ought be honest enough to tell others, especialy a fine group of folks as is found here in the Gumshoe Universe, the TRUTH in all it’s gory detail about things they try whether or not they work out. I don’t much respect people that go on and on and on about the winners they have but never mention the losers which we all know are an inevitable part of this process called investing. So, in that spirit, here’s how my day went.
    In my comment that Travis so surprisingly decided to use as last weeks “Comment of the Week” I mentioned that I was determined not to succumb to my gamblers instinct to trade the position. Even thought I had watched it rise to the $1.10 area and then fall back to about 1.00 on THREE occasions over just a week or so. Well, today that resolve to hold for long term results got washed aside with this quick price increase. I figured if I could sell here, then if the price followed that same fallback pattern sometime during the remainder of the week, I’d both lock in the quick profits then buy back about 10% or so lower than the sell. Lotta “ifs” in that sentince.
    So around noon I placed an order to sell the entire position. I went in with a 1.13 limit price – didn’t want to risk that trader dropping the bid just to take me out then immediately moving it back higher. The bid at the time was 1.13, ask 1.16. And I waited. And waited. And waited. No execution. And the day ground to a close with me still hoping that it what was happening was that situation called “stock ahead” at the bid price, That means that even though my sell order was in at the bid price, at great deal of other orders were also in at that same level that were placed before mine. They have to be filled first. Sorta like being way back in the line to get tickets for a concert. You just gotta wait your turn and hope they don’t sell out before you get to the window.
    I never got executed. Whether or not that proves to be a good thing, well, I’ll find out tomorrow. If the price pushes higher still, I may go back in with another sell order a penny or two below the bid. That will get me a trade. Or I may just not use a limit parameter at all, just take what I get. But if the price starts to retrace some of todays gains, I’ll just stand pat and try to take solace in the knowledge that I said I was in this for the long haul anyway.
    If I do sell, I’ll be back in soon. Hoping that I’m not sounding like some tout myself, or that I have fallen in love with the stock, or am shilling for Nick Hodge, or whatever other descriptive adjectives come to mind, I plan to be an owner of Stellar for the long term. The way I work these things when I trade a position I still believe will go higheris I set a 10% band on either side of the price I got out with. In this case, if I do wind up selliing at, say, 1.14, I’ll have alerts set up to tell me when the ask either drops to 1.03 or rises to 1.25 and I’ll buy it back and start again.
    Is this wise? Some might say yes – protect and make real those profits. Some might say no, why give up the spread if I really believe in higher prices long term? All I can say is that it works for me. This is high risk gambling money I’m working here and part of the thrill is not only profits but the game itself. How about any and all other Gumshoes out there like you? I’d like to know what you think.
    Is it 9:30 AM EST yet? :0)

    Like(0)

  29. Jim,
    I completely agree with you, and I believed this companies story as soon as Travis deciphered nicks tease, back when it was .65. I go to school in the university of Oklahoma, but I live in Florida, Weston/fort lauderdale area, where are you?
    Btw me and a couple of gumshoers formed a yahoo group, since we didnt want to abuse of GS, the story why we created the group is, type on GS search: Lou Basenese NFC, and down in the comments you will see all our post. Btw the company is suppose to make a huge announcement tomorrow after the close when it reports earnings, a lot of us are taking a blind gamble to, but like this one it has a believable story, hope you get this before the close, just in case you want to get in.

    Link to yahoo group hope to see you there, were in the process of accumulating members so anyone is welcome to join.
    It’s called IWSY group but its a trader chat room in its early beginnings

    http://finance.groups.yahoo.com/group/iwsy/

    Betyo

    Like(0)

    • Berto:
      Thanks for the reply. I have been so distracted of late I totally overlooked the earnings report info you mention, and I haven’t heard even a whisper about any kind of major announcement from Stellar after the close Wednesday. I’ll be watching for that closely. If the price continues to move higher today it may just be because of this coming announcement. Just remember this old market adage: “Buy on the rumor, sell on the news.” Which in this case would mean we ought be buying NOW, waiting on the announcement, and be prepared to sell on Thursday if it as good an announcement as you think it may be. We’ll see.

      I moved to Florida in ’72, settled in what was then a “new” city – Coral Springs – and stayed there until ’92. Great place to raise a family in those years. I then moved to Plantation, rented for about 4 years, and wound up building a home in Weston in ’96. Stayed there until I retired form the Financial Consiulting business and moved to Royal Palm Beach in 2003. I love it up here, close to everything in Palm Beach but far enough away to be out of the way of traffic and congestion of Broward and Dade Counties, and sort of in the country (Loxahatchee and The Acreage). I can have Sunday brunch at the Clewiston Inn with a drive West through the sugarcane fields of the ‘Glades in 45 minutes
      Or do the same by going slightly North up the Beeline Highway to Indiantown and enjoying their fantastic Sunday brunch buffet. at the historic Indiantown Inn. I’ll check out your yahoo group when I have time. Sounds interesting. Can never get enough exchange of ideas and sharing of experience where investing is concerned.

      Like(0)

  30. As a small investor who took positions about a week ago–I’ve got to say that I’m a huge fan of limpets right now! My IRA position is up almost $1,000 and my regular portfolio is up almost $2,000 in one week! Every single day the stock has been up even when the market has been hammered. My portfolio is thereby killing the S and P in large part due to a small sea snail–go escargot go!! Don’t waste these babies in a French Restaurant with butter–these babies are rocket fuel for the small investor. I’m going to ride this wave, lock in some profits soon to hedge my risk and then keep riding what looks like a huge winner. This company has a huge upside as the product looks extremely versatile and useful to the medical community.

    Like(0)

  31. When Myron Martin commented about this company on Aug 11, it was still in the .80 to .90 range. Today Aug20, it closed at 1.49. Intelligent speculation is always on the winning side.

    Like(0)

    • Thanks Henry, (I think) so now that my “intelligent speculation” has been published, are you in? If you check my record from previous columns you will find quite a few stocks that have moved up quite nicely. For the record, I give my picks at least 6 months to pay off and some may take longer, but the key remains extensive research and then PATIENCE and taking profits over say, 25% progressively until your original investment is off the table. I love playing with house money to eliminate RISK as quickly as possible.

      Like(0)

  32. Here’s a copy-and-paste from http://www.piercenet.com/browse.cfm?fldID=01010102, which has information on a product from Thermo Scientific:
    “Imject Mariculture KLH (mcKLH) is KLH that has been harvested from limpets grown in mariculture rather than captured from the wild.” I wonder if they get it from Stellar Biotech or if they do their own mariculture. Thermo Scientific sells mcKLH for $183 for 100 mg, equivalent to a price of $1830 per gram. That is lower than the $35,000 per gram cited in the teaser. It’s possible that 100 mg of mcKLH has only a little bit of pure KLH in it. But Sigma-Aldrich is specific that 20 mg of KLH in 100 ml of a solution is $72.20, equivalent to a price of $3610 per gram, 10 times less than the teaser price.
    I could not find a 10-K or 10-Q in the SEC database. I wanted to read the Risks section.

    Like(0)

    • The pitch was that most KLH is harvested from wild limpets now, killing them, and that the wild population can’t support that much longer — which is why they think their farming solution is the future. Not sure what the barriers to entry for farming keyhole limpets are, other than the proprietary knowledge built up by Stellar.

      Their primary listing is in Canada, so they don’t file a 10-K — Until recently the only place to get their annual report was through Sedar, the Canadian comparable to the SEC’s Edgar database, but they did uplist to the OTCQX so now their annual reports are in Edgar and they’re full filers with the SEC. It won’t be a 10-K, though, since they’re foreign it will be a 20-F. You can see last year’s here: http://www.sec.gov/Archives/edgar/data/1540159/000121716013000014/stellar20fannual2012final.htm

      Like(0)

  33. Travis, thanks. I see that the 20-F stated a risk at the end of the fiscal year that ended in Aug 2012 about SBOTF needing financing and uncertainty about whether the company could continue as a going concern.

    I see at http://biosyncorp.com/klh/why_use_biosyn_klh/ that biosyncorp takes keyhole limpets from the wild, extracts blood, and returns them to the wild, inconsistent with the statement in the teaser that keyhole limpets are killed by other companies. It says “biosyn returns the animals back to its natural habitat, as it is a humane approach as well ensures that the animals recovers readily…”

    Like(0)

  34. Trading has been halted in KLH.V, and SBOTF; I’ve heard from the company:

    Dear Mr. DiFrancesco,
    Thank you for your email and your interest in Stellar Biotechnologies. Stellar has placed a halt on trading of our stock (TSX: KLH, OTCQB: SBOTF) pending a news release. We will release the news as soon as possible however the timing of the news release is not yet known. Trading of the stock will resume again after the news has been released.
    Thank you again for your interest in Stellar Biotechnologies.
    Paul D. Reyes
    Stellar
    BIOTECHNOLOGIES
    332 E. Scott St.
    Port Hueneme, CA 93041
    InvestorRelations@stellarbiotech.com
    stellarbiotechnologies.com
    klhsite.com

    I’m anxiously awaiting clarification; speculation of a buyout is rampant, but nothing official, yet.

    facebook

    Like(0)

  35. Ha, So much for a buy out. It was just the company trying to make some quick bucks with an agent putting a time lease on their stock for $1.05 for three years with 12 mil upfront. What a let down..

    Like(0)

    • Yes, I was disappointed in the way Stellar locked us investors in the building, before they set it on fire. The stock gapped down $0.36, surprisingly, it bounced back $0.19, today. But I still don’t like the underhanded way they did this. Contrast that with the way Elon Musk, of Tesla, one of my best performers, does an SPO: he announces a week in advance that he’s doing an SPO, buys many of the shares himself, and in short, is honest with investors. In response, the stock jumps $20. I also wondered, if they’re so anxious to sell their shares for $1.05, WITH a warrant, why the heck doesn’t the company offer shareholders an opportunity to buy at those levels? Stellar just made themselves look bad.

      Like(0)

  36. Deborah, et al:
    Yesterday you asked me if I knew for certain what claims Nick Hodge made in his original teaser about Stellar Biotech, especially regarding any comments concerning their mariculture operations (“Farming”) and being an exclusive provider of KLH to the medical and pharmaceutical industry. I promised I’d review that original tease, this time paying special and close attention to what was being said. Sometimes we get distracted by a part of a statement and overlook a few other words that, in the end, have signifigant impact on the real meaning.
    I’ve done that and below you’ll find a few excerpts from the presentation. Direct quotes are in parenthesis, paraphrased are not.
    If you or anyone wants to watch the video directly, go to http://www.angelnexus.com/o/web/49044
    to view. Note: this presentation runs about 40 minutes in length. The first 20 minutes or so is the actual company tease. The last 20 minutes the pitch to get you to subscribe to Hodges’ advisory service, Early Advantage. This costs $499 for a year. Watch that if want but there is no additional info on Stellar Biotech presented in that segment.
    Here goes:
    (1) When blood is extracted from the Giant Keyhole Limpet, it dies. There is no mention of any company that is harvesting Limpets from the wild, extracting the blood, and then returning them to the colony where they recover. This contradicts the claim by the other company involved in this that they can and do return the animal to its natural habitat where they recover and live on.

    (2) “KLH is too big and complicated to synthesize” – A quote attributed to an article in Popular Science, the validity of which is not known. The implication is that KLH cannot be obtained in any way other than by using the Limpets blood.

    (3) Only Stellar Biotech knows how to extract blood from a Limpet without killing the animal and has a patent on the process. This is where the statements get interesting and must be carefully examined. Note that Hodge says “has a patent on it.” Could it be that other companies know how and are doing it but don’t have a patent? If the veracity of the statement is to be accepted, one must think that perhaps it is because of the inclusion of that wording about having the patent whereas no one else does.

    (4) Stellar Biotech “has the only patent-pending process for raising Keyhole Limpets on land.” Here again, don’t overlook that “patent-pending” wording. The implication one may get is that SBOTF is the only company that has developed a process for farming the animal. That’s what we want to hear. But when that phrase re the patents is included, it opens the door for other firms to also be farming Limpets with their own processes but without having any patents on it. Tricky, huh?

    (5) “This tiny biotech company that I’m telling you about today is the only company that can provide it.” (KLH). This would seem to be a complete misrepresentation.

    (6) “This company is the only one that can provide KLH in commercial quantities.” Here is a perfect statement that illustrates what I’ve said about hearing only what you want to hear and missing the qualifier. It’s the “in commercial quantities” part that is signifigant. We hear that Stellar is the only company that can provide KLH. But when you include the “commercial quantity” part it has a whole new meaning. What, exactly, is a “commercial quantity?” How much can another company produce and provide yet not have to be considered in light of this claim?

    (7) “In the near future, these guys (Stellar Biotech) could very well be the only company with any access at all to these sea snails.” The qualifer is “could very well.” Not “will be” or “are”, but “could be.” Huge difference in meaning. Yet we hear it as sounding as if they “will be.” and that’s misleading.

    (8) Brief mention is made that there is a “reclusive billionaire that owns 38% of the company.” No name is offered. This leads me to wonder – if that person does exist, and he/she has such a large stake in the company, could this be the source of the recent financing and the reason why what would appear to be a sweet deal for them was offered? I’d like to know the answer to that. It doesn’t change anything, just curious.

    I could go on but I suspect you can see now the point I’m making. A tease is carefully designed to entice interest. The claims and statements aren’t random musings – they are carefully thought out and phrased to push the idea being given yet have those few additional words that our brains tend to overlook when we are seeking to validate a hope or belief we might have. And that occurs with all of us from time to time. We just hear what we want / need to hear and run with that.

    Hope this helps. As for me, I’ve concluded that yes, there are a couple other competitors out there that are involved in trying to perfect the farming of the Limpet and have a process to produce salable KLH. But I also believe that Stellar Biotech is the frontrunner in this endeavor and will succeed. If this were a horse race I’d compare SBOTF to having my money on Secretariat rather than any other in the field. I, and I suspect most of you, are already profiting handsomely in just a few short weeks from being stakeholders. Will we ever see the fantastic returns Hodge suggests we will? I don’t know. But I will be in on it if it does reach even a fraction of those suggestions. And I’ll be in it if this entire thing folds like a house of cards.

    Best of investing to all ..
    The Blind Squirrel
    Jim Skelton

    Like(0)

    • Jim.
      Early on I believe I stated that I was able to research and determine the name of the company (at that time still KLH), from the Nick Hodge teaser. I did not listen to the majority of the teaser, as I will not allow myself to be influenced by teasers. I firmly believe the majority are paid BLOW HOLES. I spent a couple of days reading every article, news release, company web site, and back ground information on the science behind KLH. I bought KLH stock @.63, because I believed in the science and hope for the people the vaccines could help. I felt good about the care of the keyholes and the process of extraction and life after for the sea creature. I knew at that time other KLH was on the market, however not of the purity this farm produced. I invested on my own research and was not influenced by others comments. I went about my business when the hold was placed on trading, and was not swayed by others cold feet and speculation. I found this site after I bought stock in KHL/Stellar. I am in for the long haul sink or swim.

      Deborah

      Like(0)

  37. When SBOTF was at $1.00 I bought some. When it got to $1.50 something made me feel uneasy so I sold. The next day trading was stopped and then the stock dropped. I was glad that something made me get out with profit. When I sold I told myself that I would just watch it and buy again if it continued to climb. As you can see, it just fell apart. Whew!

    Like(0)

  38. KLH is not the medication but the carrier, which a few people seem to not understand.
    Stellar has recently announced contracts with a company developing a medication that fights clostiridium dif. which I understand is fatal in many cases. Along with other contracts that they already have. KLH is supposedly too large to genetically engineer.
    I do not understand exactly what their latest financing method is, buy shares at $1.05 and getting with each share 1/2 a warrent to buy a share at $1.35 in the future means, especially with the stock closing at near $1.35 on Friday. I bought in when the stock was under a dollar, the tease was too easy to figure out. Should I wait, or take my 40%+ profit and bail. I think not yet.
    KLH seem too important of an ingredient in many medicines and vaccines that are coming down the pipe. However, maybe a trailing stock sell at a 20% loss would be a good idea.

    Like(0)

    • I bought in at 0,60 and it closed today at @1.90. I’m hanging on because the daily rise recently has averaged @ 0.06 except for the huge swings when someone with a large holding takes his(her) stuff all at once. It usually takes about 7-10 days to recover and continue to march happily (for me) upward. They’ve recently got some financing from a Japanese pharma, so I’m holding on for the ride.

      Like(0)

  39. Just fell apart?
    Stellar had its highest volume day ever after the hhalt. Blessing in disguise

    Whhy put ur trailing stop at a 20% loss? Set it 20-30%+/- from te most recent 52 w high. Why stop out at a loss whhen u can be in the money

    Like(0)

  40. Thanks for all the useful information Jim–while we don’t always see eye to eye, I appreciate the time and energy you put into all of this. I still don’t appreciate the private offering by the company as I still see it as a sweet deal designed to benefit a small group (jperhaps the reclusive billionaire and a few others?) at the expense of the small investors. However, it looks like I overestimated it’s effect on the dilution of the market price as we are back to all time highs today. While the Big Dogs have an unfair advantage, we little pups can still get some crumbs. How many market shares are out there right now anyway?

    Well, it’s a good day when my portfolio is beating the S and P by nearly 10 fold. While Stellar is leading the pack, DDD (3-D printing) is not far behind in my more speculative plays and QiWi (a Russian company with excellent positioning in the lucrative Russian cash machine business), CTRIP (China’s dominant E Travel company) and NENE (my smallest holding–solar spray of technology) are all up nicely. It’s been a strange couple weeks when my speculatives have all been up and my biggest blue chip holding: JNJ has been consistently down!

    Like(0)

    • Jim,
      What would you consider a low enough dip right now to add to your position? What do you think SBOTF will do after the presentations on Sept. 9th and mid-October? I’ve done quite a bit of reading and feel somewhere in my gut that, if the stars get into alignment :), this could be big. I’ve worked in healthcare 25 years, and the thought of a vaccine for C-diff. makes the hairs on the back of my neck stand up…(not to mention the many other uses). I think KLH is the real deal, and anyone who can provide pharma-grade product consistently could hit the jackpot. I’m late to the party and have not purchased yet.

      Like(0)

      • Now is a great time to buy Jana. Stellar is already over 10% of my holdings so I can’t risk more but if I had on the sideline I’d add it now-around $1.25 is an excellent price.

        Like(0)

      • Jana:
        Welcome to Gumshoetown! You’ve found a great site that offers some specialized investment thoughts. The head honcho, Travis, unravels the mysteries of all these “Teaser” ads put out by newsletter publishers whose main aim is to get you to subscribe to their service and THEN tell you what they are talking about – sometimes useful, sometimes not. Travis does the unravelling for us and saves the bucks. Then there is Myron Martin, an absolute wizard at finding, following, and sometimes picking companies you’d probably NEVER discovefr on your own. In particular foreign-based mining companies, many trading under $1.00. His stuff is GOLD, literaly and figuratively speaking. NOTE: to see Myrons work you have to step up and become what is called an “Irregular”member of the site. Travis charges only $49.00 per year for this – Yep, only $49.00! A deal if there ever was one. Don’t think about it, don’t delay – just sign up fot that membership and get ALL the site has to offer. Last, there are the comment from Doc Gumshoe, who is not an actual M.D. but instead a medical writer of some 30 years experience. No unwarranted bias in his work – just his best judgement about the going-ons in the medical and pharma world. Few stock picks, though – not his thing. Just some thought-provoking articles on how to take better care of yourself.
        Now, about Stellar Biotechnologies.
        I bought my first shares – some 7,250 – on July 18 of this year. I’d been watching it at around $0.63 and then it POPPED with no warning to $0.92 on the 18th! I cursed myself for not acting when I got that first Gut Feeling at $0.63. But I dove in anyway. And it’s paid off nicely.
        I rode it up to about $1.55, then watched it start to decline. I sold it at $1.40 and waited. When the financing agreement was announced and the stock was halted for trading, it re-opened two days later around $1.05. If you have read all these posts, people got a little beserk and opinions flew as to what was going on. I bought back in at $1.17 and waited. Last Friday I got antsy for no particular reason and decided to sell all. I got out at $1.35. At the same time I put in a GTC order to buy 3000 shares at $1.25. Today that order went off as the price took a pretty serious hit intraday. It baunced back from the day low of about $1.15 or so and closed at $1,22. Tomorrow, if the two-day retreat continues, I plan to buy another lot of 3000 shares at $1.10. If it turns around and heads up, I’ll buy that lot at $1.30.
        There is no magic in my thinking or the price levels I have set. Just sudying the daily chart and volume stats and trying to find the middle ground for what seems to be forming up as a trading range. Forget hitting the absolute tops and bottoms – that is always a matter of pure luck – but don’t tell the boys in the techcnical analysis dept. that. They need to think they can predict that kind of thing :0).
        Are you “too late to the party?” In a word, no, I don’t think so. You pointed out a few reason why the future for SOBTF looks bright. But as a new, untested company, the road to that destination will be rocky and bumpy. And we all must admit that no matter what the outlook is, in a situation like this, that road can at any time send us careening off the side of the mountain to crash and burn. Live with that and don’t risk more than you can aford to lose.
        The easy money in SOBTF has been made. That was done when it traded from $0.125 to about $1.10 a share. The paat 52 weeks has seen a total growth of some 300%. Results of that magnitude cannot EVER be continued indefenately. A slowdown is to be expected and I think we’ve hit that point now. Oh, it’ll still provide way above average returns. But thngs lke I got in 5 weeks as outlined above where my net total return was 42%? I’ be a fool to think that would continue.
        So, for now, I trade it as I also mentioned. Looking for dimes, not dollars. Done consistently (and that’s the trick), those dimes can lead to dollars. Just maybe a little slower.
        No matter what, I’ll be in this stock long-term. I believe in it, in the products and processes and patents they already have. And I like thier business model that will pay off down the road when enough contracts with Pharma have been sealed that givve us royalities on the drugs the pharmas develop using our KLH. Annuitization of assets and capital – that’s how big money is always made.
        The upcoming presentations will be interesting, but don’t sit with breath held looking for some big news announcement. What we will get from them is increased awareness of what Stella Bio does and what we are planning on doing. This awareness can lead to increased investor interest which leads to buying which affects supply/demand factors which drives price. All good. Just wait until the day comes that a few independant research firms pick up on the idea and issure reports favorable (hopefully) for the company. Then mutual funds may began to nibble, the larger buyers come in, and BAM-MAM, the real results start to appear.
        Just get in there now and don’t fret about “good time – bad time” metrics. Any time could be either one.
        Be advised: the thoughts and opinions expressed here are those of myself alone and are NOT to be construed as a recommentation that you or anyone else buy shares of the company. That determination can ONLY be made by yourself based on your personal financial situation. No guarantee of profit is to be implied or guaranteed.
        Hope this helps you a bit ..
        Jim Skelton, The Blind Squirrel
        “Even a blind squirrel finds an acorn every now and then.”

        Like(0)

  41. You are what you put into yourself. Doesn’t take rocket science to figure out why so many people are sick. Get back to the basics of organic fruits and vegetables, buy a juicer and start juicing. A healthy liver is a healthy body. I don’t need a doctor and I don’t need medicine. End of story.

    Like(0)

  42. Short and to the point Rick, but most people simply “will not :get it” because they are too addicted to their junk foods. Everything you put into your mouth, whether drink or solid food, either builds health or it builds dis-ease, it really is that simple.

    Good health comes from good habits, it does NOT come from bottles or packaged pills filled with chemicals that interfere with the bodies natural defences against disease. If you can find a copy in a used book store, probably the single most valuable book to come out of the medical profession, (unfortunately out of print) was CONFESSIONS of a MEDICAL HERETIC by Dr. Mendelsohn who I had the pleasure of meeting personally. He was a pioneer in exposing the many skeletons in the medical closet.

    Like(0)

  43. Stellar Biotech has a great future because it has patented the harvest of a natural/organic substance which when used in vaccines for difficult to treat diseases, helps stimulate one’s own immune system. This approach is the future for medical prevention/treatment–helping one’s own immune system fight off the bacteria, viruses or out of control cell growth (cancers etc…), rather than depending mostly upon chemicals, antibiotics or radiation which destroy part of one’s own immune defenses in the effort to attack the undesired invaders.
    While I agree with many of the points that Myron, Rick and others have raised on this thread–you all are oversimplifying and using hyperbole to make your points. A good diet, good excercise habits, safe sex and lack of substance abuse, all go a very long way in helping anyone reduce her/his odds of contracting disease and/or succefully fighting off such diseases when they are contracted. Genetics, environmental factors and unknown factors also play a huge role. As a walker/jogger/hiker, I’m reminded of the following story from about 25 years ago: “A guy rolls down the window of his car as he passes a jogger and yells out: ‘Jim Fixx is dead; Fats Domino lives!’ “

    Like(0)

  44. David: your point about genetics is well taken, but it reminds me of the scripture that says;
    “I will visit the sins of the fathers to the 3rd and 4th generation” meaning that it may take 3 or 4 generations to REVERSE what the past generation has brought upon itself by “riotous living” ignoring the rules of good health. It is true that some people manage to defy the odds, but eventually, even if it takes generations, poor lifestyle habits will augment disease and GOOD lifestyle habits will can reverse pathology as the immune system is strengthened with good nutrition and general cleanliness of lifestyle.

    Like(0)

  45. I received the tease from Nick Hodge as an advertisement and was very easily able to solve what it was before I found this (stockgumshoe.com) site. I had recently retired, as a pharmacist, and was looking for something to do. I was intrigued by what they were supposedly doing so I bought 2000+ shares when it was at $0.73 after I had seen it move for the past couple of days. I sold some of that to buy another company on 10/30/2013, at $1.88 per share. it has gone but to $2 and above, that seems to be where it has meet with price resistance. I did get a little nervous when the sold additional shares at $1.05 with the promise of buying 1/2 of another share for $1.35 to raise additional revenue.
    I feel that this stock has now run most of its rapid rise, but I left some money in it because I like what they are doing.
    I did not purchace Nick’s book, and so far as I have seen most of his other picks have gone nowhere (that is a personal not legal opinion).
    Now for a tip that has gone up 50% since early this week, and should go up another 100% in the next few weeks, check stocktips.com they will give it to you for nothing. I am not paid by them so check it out if you wish.

    Like(0)

  46. Wow! I again got more out of the medical discussions than the investment advice. Caution: We need to listen to everyone and just do the math to see that is true. Both sides to this issue have demonstrated abject failures. The alipaths failures are pretty much on the record, and although there are many testimonials for the alternatives some of these apolygists (sp) have never really been exposed to serious disease. I am 80 and have dreams of living to the age of my mothers sister who will be a healthy 105 in March. I have eaten healthily and excercised all my life. Unfortunately I have something wrong with me that prevents me from sleeping longer than four hours. Alipaths can only match the symptoms with a pill and the only homeopath I have used seems to be a charlatan (lots of dollars with no results). I just want a diagnosis. Thank you again Travis for this site, your sincerity and your honesty.

    Like(0)

  47. Dennis: I’m thinking you’ve had one too many tokes of that medical weed you suggest Leo began. Don’t get me wrong – I am a proponent of legalization of MJ and know it does help relieve pain plus other benefits. One might say it’s God’s own contribution to our human frailty. Just don’t get stoned, get stupid, and drive! Or try to explain the theory or relativity.
    As for wiping out the Giant Keyhole Limpet via an oil spill, tell me this: How will that oil make it’s way into the aquaculture tanks that Stellar has up and running? And what are the odds a spill will occur dead in the middle of that very small patch of ocean where the colony exists?
    There is room for both approaches here. And you’e far more likely to make money farming Limpets for the KLH than farming weed for their chemical compounds (THC?). And far less likely to be arrested as well.
    When your head clears, think about that, would you? :0)
    JIm Skelton
    The Blind Squirrel

    Like(0)

  48. Stellar has partnered with Amaran Biotechnology to evaluate methods of manufacturing of Amaran’s drug OBI-822 active immunotherapy, using Stellar’s GMP grade KLH, for the treatment of metastatic breast cancer, in Phase II/III trials in the United States, South Korea, Taiwan, India, and Hong Kong, and Phase I/II trials for the treatment of ovarian cancer, in Taiwan.

    Amaran has built the factory, and Stellar will be responsible for the production of GMP Grade KLH, for evaluation as the carrier molecule in OBI-822 immunothera;y, and for methodology, formulation, and qualification of KLH reference standards, for which Amaran will pay Stellar. Additionally, Amaran might seek a future commercial supply agreement for KLH, with Stellar.

    More info:
    http://www.contractpharma.com/contents/view_breaking-news/2013-12-13/stellar-amaran-enter-manufacturing-pact/#sthash.J5c4irly.dpuf

    Like(0)

  49. Someone recently commented on this bblog abot the “risk / reward” equation when it comes to new technology. He used GE as his example of a company bringing a new technology to the market (in this case it was electricity to the Nation) and by so doing being the cause of some 300,000 house fires each year that kead to 3,000 deaths and and around 8 billion dollars in damages each year. His question was is that “acceptable risk / return?”
    Are you kidding me? It most certainly was and is!
    Does the writer think there were no fires and deaths and property damage before homes and business were electrified? Maybe like the fires that nearly burned both the entire cities of Chicago and San Francisco to the ground in the late 1800′s? And how, without electricity, would be be getting on as a Nation and a people today? Still cooking on open fires and freezing to death in the winters. Etc., etc., etc.
    Honestly .. what are you thinking, sir? Technology almost ALWAYS presents some new risk that will cost us. But the benefits? The benefits so much outweigh those new risks as to be immeasurable.

    Like(0)

  50. Stellar has been taking a beating for the past few days. Other than a general malaise in the market, as a whole, I can’t see the reason why.

    Like(0)

  51. I’ve got some dry powder…might pick up a few more shares at these prices…like to see a bottom form, though…looks like it wants to go down some more, short term.

    Like(0)

  52. Spot on with this write-up, I actually feel this web site needs much more attention.

    I’ll probably be returning to see more, thanks for the information!

    Like(0)

  53. I read somewhere, that Frank Oakes’ wife sold her 500,000 shares at $1.50. I HAVE wondered where the heck all the selling–started in April–is coming from; somebody’s sure selling a ton, and cheap. Given the size of the orders, I’m thinking: “Insiders”. Today’s Time & Sales indicate that there are over a million shares at the $1.01 Ask. As usual, Stellar is keeping mum on this and pretty much everything else. And with the missus dumping her shares, it’s hard to believe there’s any good news on the horizon. It frankly appears that the stock wants to go down some more.

    Like(0)

  54. This, undoubtedly, was one of Mexican businessman and CPA Ernesto Echavarria’s buys; I’ve been reading up on him and his dozens of what are described only as “Buys or Dispositions” of shares of Stellar. Unfortunately, they don’t give clear information on whether each transaction is a Buy or a Sell. Elsewhere, I did read that he holds over 20% of the float. He is also an insider (i.e., holder of at least 10% of shares) of several other companies–he seems to have a sweet tooth for Canadian Juniors–and has a controlling interest in Frank’s fruits and vegetables in Mexico. Several of the companies in which he is an insider have earned the attention of the SEC. I ran into a blogsite entitled “Neer do well Hall of Infamey” Here’s a link:

    http://neer-do-well-hall-of-infamey.blogspot.com/p/clive-massey.html

    You’ll read, here also of many companies in which shareholders lost millions, such as:

    http://www.mineweb.com/mineweb/content/en/mineweb-junior-mining?oid=187170&sn=Detail

    Rye Patch Gold (RPMGF), Redhill Resources (ATWGF), Animas Resources (Sold to GoGo Gold, Copper Fox Metals. And there’s Solotro, Blackheath Resources. The list goes on and on, and the same people keep showing up.

    Is Mr. Echvarria complicit in these deals? I’m not aware that he’s been charged, but I find it very suspicious that he seems to be an insider in a lot of these companies, where shareholders lost their shirts.

    And I have to say that the massive selloff in Stellar, since early April smells of burnt investors.

    Like(0)

  55. The last few days have certainly been nice…lots of heavy buying in Stellar, and double digit percentage gains…just about recouped from the recent drop. Haven’t seen any news, however. It’s hard telling what’s caused all the sudden interest.

    Like(0)

  56. Well, well, well, the last three days have seen a 41% jump, from $0.92 to $1.40, and on huge…35X average daily volume. I suspect this huge jump has something to do with Michael Robinson releasing a promotion to sell his Money Morning Prospectus, with a reference to “Living Metal”, which calls KLH something else and calls the Keyhole Limpet something else. Travis has that covered. here:

    http://www.stockgumshoe.com/reviews/radical-technology-profits/liquid-metal-tiny-company-has-monopoly-141478-for-a-thimbleful/

    But there is also other news: Stellar to be listed on the major exchanges, several Big Pharma companies lining up to ink a deal with Stellar. A lot of this may be hype, or it may be true; I’ve been hearing it for quite some time. But what is an absolute fact is that our volume was 1.75 million shares traded today, 1.25 million shares traded yesterday, and another 0.5 million shares sold Monday. Let’s see how it goes tomorrow.

    Like(0)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

What These Icons Mean

  • The user who posted this comment is a Stock Gumshoe Premium Member (also known as an "IRREGULAR").
  • This user regularly writes articles for Stock Gumshoe. They may or may not be the author of the current article.
  • This user's comments have been "liked” by at least a few members of the Stock Gumshoe community.
  • This user has commented widely, with input that has been liked enough to earn a two-thumbs-up rating from other readers.
  • This is the highest rating a user can get. They are among the most respected commentors of our community.